left-caret
Image: Irina He

Irina He

Associate, Corporate Department

Beijing

Phone: +86-10-8567-5349
Fax: +86-10-8567-5400

Overview

Irina He is a member of the Corporate Department of Paul Hastings’ Beijing Office. Her practice focuses on corporate market transactions, especially advising Chinese companies and financial institutions on listing and issuing bonds on the Hong Kong Stock Exchange. Irina’s professional experience spans multiple sectors including consumption, TMT, online education and healthcare.

Prior to joining Paul Hastings, Irina worked in other domestic and international law firms. She is fluent in Mandarin and English.

Education

  • Boston College Law School, J.D.
  • The University of Hong Kong, B.SocSc

Representations

  • BlueFocus Intelligent Communications Group Co., Ltd. on its A to H listing on the Main Board of the Hong Kong Stock Exchange.
  • LXJ International Holdings Limited on its global offering and listing on the Main Board of the Hong Kong Stock Exchange.
  • CICC and Haitong on the HK$320 million global offering of Unisound AI Technology Co., Ltd. and its listing on the Main Board of the Hong Kong Stock Exchange.
  • CICC on the US$300 million global offering of Mao Geping Cosmetics Co., Ltd. and its listing on the Main Board of the Hong Kong Stock Exchange.
  • CICC and CMBI on the HK$700 million global offering of Carote Ltd and its listing on the Main Board of the Hong Kong Stock Exchange. 
  • Morgan Stanley, CICC and CSCI on the HK$820.3 million global offering of Shiyue Daotian Group Co., Ltd. and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Morgan Stanley and CICC on the HK$238.9 million global offering of Beisen Holding Limited and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Onewo Inc on its US$738 million global offering and spin-off listing its H Shares on the Main Board of the Hong Kong Stock Exchange.
  • Chongqing Hongjiu Fruit on its US$72 million global offering and listing of its H Shares on the Main Board of the Hong Kong Stock Exchange.
  • CICC and CMBI on the US$51.6 million global offering of Dingdang Health Technology Group Limited and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Morgan Stanley, CICC and UBS on the US$130 million global offering and IPO of Weilong Delicious Global Holdings Ltd.
  • Kangqiao Service Group on its global offering and listing on the Main Board of the Hong Kong Stock Exchange.
  • Morgan Stanley and CICC on the US$394.5 million global offering of Cheerwin Group Limited and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Morgan Stanley, CICC and Credit Suisse on the US$281 million global offering and IPO of SciClone Pharmaceuticals.
  • Other ongoing Hong Kong IPO projects.

Languages

English


Admissions

New York Bar


Education

Boston College Law School, J.D. 2019

University of Hong Kong, B.S.Sc 2015